Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy
- PMID: 22649128
- DOI: 10.1200/JCO.2012.42.2436
Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy
Comment on
-
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.J Clin Oncol. 2012 Feb 10;30(5):533-8. doi: 10.1200/JCO.2011.34.6890. Epub 2012 Jan 9. J Clin Oncol. 2012. PMID: 22231041 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical